Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 97%
filed 2026-09-02
Item 1.01
cbdMD entered into a definitive Asset Purchase Agreement on September 1, 2026, to acquire the operating assets and brands of Twinlab (including Twinlab, Reserveage, Metabolife, and Alvita Tea) for approximately $1.75 million in assumed debt, 2,229,805 shares of common stock (19.9% of outstanding shares), and assumption of liabilities. The transaction is expected to increase combined revenues to approximately $30 million (a 40% increase) and materially expands cbdMD's multi-brand consumer wellness platform into supplements, sports nutrition, and longevity categories.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-09-02
Item 5.02
The filing discloses both a resignation (Vincent J. Arnone stepping down as Chairman effective September 15, 2026) and an appointment (Sharon L. Jones elected as Chairman effective September 16, 2026). While both events occur, the principal action centers on the appointment of a new Chairman to fill the vacancy, making exec_appointment the most salient classification. The change in board leadership is material to investors assessing governance and strategic direction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-02
Item 1.01
EVI Industries completed the acquisition of substantially all assets of Sudsies On-Site and the personal goodwill of founder Jason Loeb in Sudsies, Inc. for approximately $8.0 million in cash on September 1, 2026. This marks EVI's first strategic expansion beyond commercial laundry into consumer garment care services and is expected to be accretive to earnings.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-09-02
Item 8.01
The filing discloses that Edible Garden regained compliance with Nasdaq's minimum bid price rule ($1.00 per share) following a July 27, 2026 Hearings Panel decision, but remains subject to a mandatory one-year Panel Monitor through August 31, 2027. Critically, the disclosure explicitly states that any future non-compliance during the monitoring period will result in immediate delisting without opportunity for additional cure periods or compliance plans. The Nasdaq Hearing Panel also maintains jurisdiction through November 23, 2026, with authority to immediately delist if the company fails to maintain the bid price rule. This is a material delisting-risk disclosure under Item 8.01, as it describes the company's precarious listing status and the heightened consequences of future non-compliance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-09-02
Item 1.01
The filing discloses a waiver and consent agreement between VolitionRx and Lind Global Asset Management that permits the Company to conduct unlimited ATM (at-the-market) offerings without triggering prohibited transaction covenants or events of default under existing convertible debt and warrant agreements. The waiver explicitly removes restrictions on ATM sales that previously capped permitted sales at $10 million per calendar year, allowing dilutive equity issuances in excess of that threshold. This is material because it materially expands the Company's ability to raise capital through dilutive equity offerings and removes contractual constraints that previously limited such issuances.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-02
The filing discloses a state-led infrastructure initiative (West Susitna Access Project) with $25 million in authorized funding from the Alaska Industrial Development and Export Authority (AIDEA) to advance geotechnical and engineering work for a road connecting the Company's Whistler Gold-Copper Project to existing infrastructure. This is a material operational/strategic milestone for the Company's development prospects, though it is not a transaction the Company controls and is disclosed under Item 7.01 (Regulation FD Disclosure) as a press release update rather than a formal Item event.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-09-02
The 6-K discloses the appointment of three new directors to Basel Medical Group's board: Mr. Yang Xinwen, Ms. Cao Juan, and Mr. Frederick Hong. While two incumbent directors (Fung Keng Leong and Tan Boon Chye) departed, the principal disclosed action is the addition of three new board members with detailed biographical information and expected contributions to governance and strategic leadership. This constitutes a material executive appointment event affecting board composition and governance capabilities.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-09-02
Katharyn Field, the Chief Financial Officer (principal financial and accounting officer), formally resigned on August 27, 2026, due to personal reasons with no dispute or disagreement cited. While the filing also discloses that CEO Grady Ryther will serve as Interim CFO, the principal disclosed action centers on the departure of the CFO, making exec_departure the most salient classification. The departure of a principal financial officer is material to investors assessing management continuity and financial oversight.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-09-02
EX-99.1
Black Titan announced full conversion of a senior unsecured convertible note into 2,924,082 ordinary shares. While the note was originally issued in January 2026, this announcement discloses the completion of the conversion event itself, which results in significant dilution to existing shareholders. The conversion of $1,515,000 principal into nearly 3 million shares represents material equity dilution that would affect a reasonable investor's assessment of ownership and earnings per share.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-02
The filing discloses completion of an initial $4.6 million closing under an ongoing $9 million private placement of convertible preferred shares to accredited investors, with an additional $4.4 million in subscription documents executed and pending fund clearance. This is a classic dilutive equity issuance (unregistered sale of securities) that raises capital for the company and dilutes existing shareholders. The press release explicitly references the Purchase Agreement and the issuance of convertible preferred shares and warrants, which are hallmarks of a dilutive private placement.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-02
Presidio Property Trust announced commencement of an exchange offer to exchange all outstanding shares of its 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock for newly issued shares of Series A Common Stock at a ratio of 5.5 common shares per preferred share. This is a material capital restructuring that affects the company's equity structure and would materially affect a reasonable investor's assessment of the registrant's capitalization and ownership. While technically an exchange rather than a traditional M&A transaction, it represents a significant change in the company's capital structure and security composition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-09-02
The filing discloses a change in control of the registrant under Item 5.01. On August 21, 2026, Rik Deitsch transferred 12 million shares of Series B Preferred Stock (possessing supermajority voting rights) to Pure Raw Supplies, LLC as a gift. This transfer resulted in Pure Raw Supplies, LLC acquiring 62.63% of total voting power and becoming the controlling stockholder. A change in control constitutes a material acquisition or change-of-control event that would significantly affect a reasonable investor's assessment of the company.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-02
Item 8.01
The filing discloses a postponement of a special stockholder meeting from September 3 to September 9, 2026, to allow additional time for proxy solicitation and stockholder consideration of proposals, including an amendment to Milestone Events terms. This is a governance event involving stockholder voting procedures and meeting administration that does not fit a specific named governance category (not an appointment, departure, compensation, or vote results), making it appropriately classified as governance_other. The postponement is material as it affects stockholder participation and the timing of corporate decisions.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-09-02
Digital Brands Group announced execution of a binding contract for $3.3 million in guaranteed cash flow from September through December 2026, representing the first tranche of a larger $165 million U.S. Program over two years. This is a material operational/strategic business event—a significant contract milestone—that does not fit the specific categories of earnings release, debt issuance, or M&A activity. The disclosure is filed under Item 7.01 (Regulation FD Disclosure) and relates to a material business contract and cash flow commitment that would affect investor assessment of the company's near-term liquidity and strategic progress.
View raw filing on EDGAR →
6-K
Auditor Change
confidence 95%
filed 2026-09-02
The 6-K discloses termination of WWC, P.C. as independent registered public accounting firm on September 1, 2026, and simultaneous appointment of HTL INTERNATIONAL, LLC as the new auditor, both approved by the Audit Committee and Board of Directors. The filing explicitly addresses Item 16F disclosure requirements for auditor changes under Form 20-F, confirming no disagreements or reportable events with the prior auditor.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-02
The filing discloses under Item 5.02 that Deven Jain resigned as a director of BranchOut Food Inc. on September 2, 2026. The resignation of a director is a governance event that materially affects the composition of the board and is reportable as an executive departure. The filing explicitly states the resignation was not due to disagreement, which is standard disclosure language for director departures.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-09-02
The filing discloses a written notice from Nasdaq on August 27, 2026, indicating that ARC Group's warrants failed to comply with Nasdaq Listing Rule 5452(b)(C) because the aggregate market value of outstanding warrants fell below the required $1 million minimum. The company has 45 days to submit a compliance plan and up to 180 days to regain compliance, with explicit acknowledgment that failure to do so could result in delisting notice. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-09-02
The 6-K discloses a first amendment to an existing loan agreement dated August 27, 2026, between Seamless Group Inc. (a wholly-owned subsidiary of Currenc) and Moca Services Limited. The amendment extends the maturity date from three months to fifteen months after closing and modifies key terms including collateral provisions and capital raise conditions. While this is technically an amendment to existing debt rather than a new issuance, it materially modifies the terms and obligations of a direct financial obligation and represents a significant restructuring of the debt arrangement that would affect investor assessment of the company's capital structure and liquidity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-02
Data443 entered into a definitive Business Combination Agreement with Four Leaf Acquisition Corporation on August 27, 2026, involving a reverse merger structure where Data443 will become a wholly-owned subsidiary of a newly formed entity (NewCo) expected to list on Nasdaq. This is a material acquisition/change of control transaction disclosed under Item 1.01, with merger consideration based on Data443's equity value and a reference price of $10.00 per share, plus a required debt conversion of at least $10 million. The transaction is subject to stockholder approvals and regulatory conditions but represents a definitive commitment to a material business combination.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-02
The filing discloses entry into a definitive Business Combination Agreement dated August 27, 2026, between Four Leaf Acquisition Corporation (SPAC), its merger subsidiary, and Data443 Risk Mitigation, Inc. The agreement contemplates a two-step merger structure resulting in Data443 becoming a wholly-owned subsidiary of a newly formed entity (NewCo), with merger consideration of up to 60 million shares of NewCo common stock based on Data443's equity value at a $10.00 reference price per share. This is a material acquisition/change of control transaction requiring stockholder approval and SEC registration (Form S-4), with the combined company expected to list on Nasdaq.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-02
SRX Global entered into a material secured financing transaction with CERo Therapeutics Holdings, Inc., acquiring a Consolidated Senior Secured Promissory Note with a maximum aggregate loan amount of $11,666,108.77 (consolidating prior notes of $5,666,108.77 plus up to $6,000,000 in additional advances). The filing discloses the Note's terms, interest rate (10% per annum, 24.99% upon default), maturity date (October 15, 2026, extendable), security interests in CERo's subsidiary equity and substantially all subsidiary assets, and a guaranty by the subsidiary. This is a creation of a new direct financial obligation for SRX Global as the lender/creditor, disclosed under Item 1.01 (Entry into a Material Definitive Agreement).
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-02
The filing discloses a private placement of 2,036,659 shares of common stock (or pre-funded warrants in lieu thereof) plus Series N-1 and Series N-2 warrants to purchase an aggregate of 4,073,318 additional shares, for gross proceeds of approximately $5.0 million. This is an unregistered sale of equity securities under Section 4(a)(2) and Regulation D, structured as a PIPE-like transaction with multiple warrant tranches. The dilutive nature is evident from the warrant exercise prices ($2.33 per share) and the callable Series N-1 warrants tied to FDA 510(k) clearance, indicating a capital raise by a small-cap medical device company (Nasdaq: INBS).
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-02
EX-99.1
This press release announces the discovery of oil at the K-29 well in the Kruh Block and the imminent commencement of production operations. The discovery of producible oil and the transition to production at a newly drilled well represents a material operational milestone for an oil and gas exploration and production company. While not fitting the specific categories of earnings release, M&A activity, or material impairment, this operational achievement—particularly the note that the well may produce naturally without fracturing—is clearly material to investors' assessment of IEC's business prospects and asset value.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 85%
filed 2026-09-02
Item 3.01
The Company notified Nasdaq on August 28, 2026 of non-compliance with Nasdaq Listing Rule 5605(c)(2) due to insufficient Audit Committee members following Mr. Yuji Ishida's resignation. Although the Company subsequently regained compliance by August 31, 2026 through Mr. Kevin Cheong Jia Jin's appointment and Nasdaq confirmed closure of the matter on September 1, 2026, the Item 3.01 disclosure itself documents a material delisting risk event—the triggering non-compliance with a continued listing standard. This is material to investors as it represents a temporary but real threat to the Company's continued listing status.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-09-02
The filing discloses the departure of Nicholas Tsahalis as Chief Executive Officer and Director, effective August 21, 2026, with a Separation and Release Agreement providing 12 months of base salary continuation ($287,800) and COBRA coverage. While the filing also includes Item 5.02(c) appointments of Mark Speck as President and John Pickeral as Executive Vice President/COO, the primary and most salient event is the CEO's departure, which is material to investors assessing leadership continuity and governance.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-09-02
EX-99.1
The exhibit announces the closing of a material acquisition of Meals Through Seasons Limited for US$510 million in aggregate consideration, comprising 150 million Class A ordinary shares and US$360 million in unsecured convertible promissory notes. The transaction closed on September 2, 2026, following the stock purchase agreement entered into on August 11, 2026. This is a completed material acquisition that would materially affect a reasonable investor's assessment of the registrant's financial condition and business strategy.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-09-02
Item 5.07
This Item 5.07 disclosure reports the results of Doximity's 2026 Annual Meeting of Stockholders held on August 27, 2026, including voting outcomes on three proposals: election of two Class II directors (Kevin Spain and Timothy Cabral), ratification of Deloitte & Touche LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. The filing directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-02
Item 3.02
Wheeler Real Estate Investment Trust issued 2,962,147 shares of common stock in unregistered exchanges with existing preferred stockholders on August 28 and September 1, 2026. The issuance was conducted under Section 3(a)(9) of the Securities Act and involved no cash proceeds, representing a significant dilution to existing common shareholders. The aggregate share count increase and the unregistered nature of the offering are material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-02
Item 5.02
Philip J. Boeckman is appointed as Chief Legal Officer effective October 1, 2026, a named executive officer role overseeing legal functions. While Renee L. Wilm's transition to Senior Advisor represents a departure from her prior role, the principal disclosed action centers on the appointment of Boeckman to a material C-suite position. The detailed background on Boeckman's qualifications and experience underscores the significance of this appointment.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-02
Item 1.01
Cal-Maine Foods entered into a Second Amended and Restated Credit Agreement on August 31, 2026, establishing a $250 million senior unsecured revolving credit facility with an accordion feature permitting up to an additional $250 million and a five-year term maturing August 31, 2031.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-09-02
Item 8.01
News Corporation disclosed daily buy-back notifications under its $1 billion repurchase program authorized July 15, 2025, with approximately $458.3 million already deployed as of September 2, 2026. The Item 8.01 disclosure reports specific repurchase activity (11.5 million Class A shares and 54,641 Class B shares purchased on September 2–3, 2026) at prices ranging from $22.20 to $31.58 USD. Share repurchase programs constitute a form of capital return to shareholders and are classified as dividend_distribution under the taxonomy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-02
Item 2.02
This is a clear earnings release disclosing Sprinklr's Q2 fiscal 2027 financial results for the quarter ended July 31, 2026. The press release (Exhibit 99.1) presents comprehensive financial highlights including total revenue of $213.7 million (up 1% YoY), subscription revenue of $194.8 million (up 3% YoY), operating income, net income per share, cash position, and forward guidance for Q3 and full-year fiscal 2027. This is a standard quarterly earnings announcement filed under Item 2.02 and is material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-02
Item 5.02
The filing discloses the appointment of Anish K. Shah as Vice President & Controller and principal accounting officer of Murphy USA, effective September 1, 2026. While the disclosure includes compensatory details (base salary of $360,000, bonus and equity targets, and a $25,000 sign-on bonus), the principal disclosed action is the appointment of a named executive to a key accounting and financial reporting role. This is material to investors as the principal accounting officer is responsible for financial statement preparation and internal controls.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-02
Item 2.02
C3.ai issued a press release on September 2, 2026 announcing financial results for fiscal Q1 ended July 31, 2026, disclosing revenue of $52.4 million, free cash flow of $2.1 million, and non-GAAP operating loss of $36.2 million. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for earnings releases. The disclosure includes detailed financial highlights, guidance for Q2 and full-year FY2027, and management commentary on the company's turnaround progress.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-09-02
Item 5.02
Jeff Epstein, former Oracle CFO and current Bessemer Venture Partner with board experience at Autodesk, Twilio, and AvePoint, was appointed to Zoom's Board of Directors effective August 31, 2026, and assigned to the Audit Committee. Jonathan Chadwick's resignation from the board was also disclosed in connection with this transition.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-09-02
Item 8.01
The filing discloses a declaration of a quarterly cash dividend of $0.0625 per share of Class A common stock, payable on September 24, 2026, to shareholders of record as of September 14, 2026. This is a routine but material dividend distribution that affects shareholder value and is a standard capital allocation decision that investors monitor.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-09-02
Item 2.02
Daktronics disclosed fiscal 2027 first quarter financial results for the period ended August 1, 2026, reporting net sales of $234.6 million (7.1% growth), operating income of $24.9 million, diluted EPS of $0.40 (up 21.2%), and a product backlog of $311.3 million.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-09-02
Item 5.02
The Board approved on September 1, 2026, an increase in President and CEO Ramesh Jayaraman's base salary to $600,000 annually (effective September 13, 2026) and a corresponding increase in his target cash incentive to 100% of base salary under the fiscal 2027 plan.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-09-02
Item 8.01
The Board voted on September 1, 2026, to terminate the Fiscal 2017 Repurchase Program and implement a new Fiscal 2027 Repurchase Program authorizing $34.5 million in share repurchases, with $4.4 million already executed during Q1 FY2027.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-02
EX-99.1
This press release announces a strategic partnership and product integration: Tencent Cloud's WorkBuddy AI tools will be integrated with Flyme AIOS (which ECARX has entered into a definitive agreement to acquire). The disclosure emphasizes the joint development of AI capabilities across the Flyme ecosystem and deployment across multiple platforms including Flyme Auto. While the underlying Flyme acquisition is material M&A activity, this exhibit itself focuses on the operational and strategic product integration announcement rather than the acquisition event itself, making it an operational partnership/product milestone that would be material to investors assessing ECARX's technology roadmap and competitive positioning.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-02
Item 2.02
Item 2.02 discloses Tilly's earnings press release for Q2 fiscal 2026 ended August 1, 2026, furnished as Exhibit 99.1. The press release reports quarterly financial results including net sales of $163.5 million (up 8.1%), net income of $8.4 million ($0.27 per diluted share), and highlights three consecutive quarters of double-digit comparable sales growth and fifth consecutive quarter of profit improvement. This is a standard earnings release disclosure material to investors assessing the company's financial performance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-09-02
Item 1.01
Senti Biosciences amended a Securities Purchase Agreement authorizing the issuance and sale of $2.0 million in aggregate principal of Senior Secured Convertible Notes by Midco to NSG BioInnovation Fund, L.P., creating a new direct financial obligation.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-09-02
Item 3.01
Senti Biosciences received formal notice from Nasdaq on August 27, 2026 of non-compliance with the Minimum Bid Price Requirement (stock closing below $1.00 for 30 consecutive trading days) and the Stockholders' Equity Requirement (stockholders' deficit of $3.4 million versus $2.5 million minimum), with 180-day compliance periods granted but potential delisting if deficiencies are not cured.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-09-02
Item 5.02
Hugh Frater, a Board member, has notified the Company of his conditional intention to resign if Vishal Garg (the former CEO and current director) assumes any executive role. This is a governance event involving a director's conditional departure tied to another director's potential appointment to an executive position. While it signals board-level conflict or disagreement over leadership, it is a conditional notice of intention rather than an actual departure or appointment, making it best classified as governance_other rather than the more specific exec_departure category.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-02
Item 5.02
Dave Hulays was appointed as Senior Vice President and Chief Financial Officer of The Hershey Company effective September 2, 2026, succeeding Steven E. Voskuil who transitioned to Senior Vice President, Strategic Projects.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-09-02
Item 1.01
GoPro entered into an Agreement and Plan of Merger with Action Acquisitions LLC and its subsidiary Starman Optical, Inc. on September 1, 2026, whereby GoPro will merge with Merger Sub and become a subsidiary of Parent. The merger consideration includes 0.1 shares of Parent common stock and $1.14 cash per GoPro share. This is a material change of control transaction requiring stockholder approval and satisfying Hart-Scott-Rodino conditions, clearly constituting a material acquisition/merger under Item 1.01.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-09-02
Item 8.01
The filing discloses a declared dividend of $11.03 per share on the Company's common shares, payable on September 30, 2026 to shareholders of record as of August 31, 2026. This is a straightforward dividend distribution declaration, material to shareholders as it represents a direct return of capital and affects investment valuation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-09-02
Item 2.02
Snowflake issued a press release on September 2, 2026 announcing financial results for the fiscal quarter ended July 31, 2026 (Q2 FY2027). The disclosure includes product revenue of $1.49 billion (37% YoY growth), net revenue retention of 126%, updated full-year guidance raising product revenue growth to 36%, and detailed GAAP and non-GAAP financial metrics. This is a standard quarterly earnings release attached as Exhibit 99.1 and disclosed under Item 2.02, which is material to investors assessing the company's financial performance and forward guidance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 65%
filed 2026-09-02
Item 5.02
Yu-Ting Su resigned as director, chairman and chief executive officer on September 2, 2026, effective upon successor appointment. While the filing also discloses two concurrent appointments (Shao-Hsiang Shih as chairman and Jing-Zhou Chen as CEO/CFO), the primary disclosed action centers on the departure of the sitting CEO and chairman, making exec_departure the most salient event. The confidence is moderate because the filing presents a simultaneous leadership transition with multiple appointments, which could also support an exec_appointment classification; however, the opening paragraph emphasizes Su's resignation as the triggering event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-09-02
Item 2.02
HPE issued a press release on September 2, 2026, disclosing record financial results for its fiscal quarter ended July 31, 2026, with revenue of $12.2 billion (up 34% YoY), record operating profit (GAAP OP up 464% YoY), and raised full-year and fiscal 2027 guidance.
View raw filing on EDGAR →